Report cover image

MEA Pharmacogenetic Testing Market - Industry Trends and Forecast to 2033

Publisher Data Bridge Market Research
Published Oct 01, 2023
Length 181 Pages
SKU # DAABD18360506

Description

MEA Pharmacogenetic Testing Market - Industry Trends and Forecast to 2033


The Middle East and Africa pharmacogenetic testing market is expected to reach USD 240.34 million by 2030 from USD 159.73 million in 2022, growing at a CAGR of 5.4% during the forecast period of 2023 to 2030.
Market Segmentation
Middle East and Africa Pharmacogenetic Testing Market, By Type (Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, and Single Gene Tests), Gene Type (CYP2C19, CYP2D6, CYP2C9 AND VKORC1, CYP1A2, HLA-B*1502, HLA-B*5701, CYP2D, OPRM1, ONCOTYPE DX AND MAMMAPRINT, DRD3, D4D4, SLC6A4, HTR2A/C, TMPT, and Others), Drug Type (Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, and Over-the-Counter Medications), Sample (Blood and Saliva), Therapeutic Area (Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology & Hypersensitivity, Dermatology, Gynecology, Oncology, Neurology, and Others), Application (Clinical Practice, Drug Development, and Drug Regulation), End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Research Centres and Academic Institutes, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, and Direct-to-Customer Services), Country (South Africa, Saudi Arabia, U.A.E., Israel, Egypt, and rest of Middle East and Africa) - Industry Trends and Forecast to 2030

Overview of Global Pharmacogenetic Testing Market Dynamics

Driver
• Rapid technological advancement and miniaturization
Restrain

• Environment and health concerns
Opportunity

• Rising research and development and innovative technologies

Market Players

Some of the major market players operating in the Middle East and Africa pharmacogenetic testing market are:

• Thermo Fisher Scientific
• Illumina, Inc
• QIAGEN
• Sonic Healthcare
• BGI

Table of Contents

181 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Middle East And Africa Pharmacogenetic Testing Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Dbmr Market Position Grid
2.7 Multivariate Modelling
2.8 Type Lifeline Curve
2.9 Market End User Coverage Grid
2.10 Secondary Sources
2.11 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’sfive Forces
4.3 Industry Insights And Strategic Analysis
5 Market Overview
5.1 Drivers
5.1.1 Increasing Adoption Of Personalized Medicine
5.1.2 Advancements In Genomic Technologies
5.1.3 Increasing Chronic And Complex Diseases
5.1.4 Role Of Pharmacogenetic Testing In Drug Discovery And Development
5.2 Restraints
5.2.1 Dependency On The Medical And Genomic Expert For Result Interpretation
5.2.2 Ethical And Privacy Concerns Associated With Pharmacogenetic Testing
5.3 Opportunities
5.3.1 Integration With Electronic Health Records (Ehrs)
5.3.2 Artificial Intelligence (Ai) And Machine Learning Integration In Healthcare
5.4 Challenges
5.4.1 Challenges In Clinical Implementation Of Pharmacogenetics
5.4.2 Complexity Associated With Pharmacogenetic Testing Results
6 Middle East And Africa Pharmacogenetic Testing Market, By Type
6.1 Overview
6.2 Whole Genome Sequencing
6.2.1 Next Generation Sequencing (Ngs)
6.2.2 Sanger Sequencing
6.3 Whole Exome Sequencing
6.3.1 Next Generation Sequencing (Ngs)
6.3.2 Sanger Sequencing
6.4 Array-based Tests
6.4.1 Glass Slide Arrays
6.4.2 In—situ Synthesized Arrays
6.4.3 Self Assembled Arrays
6.5 Single Gene Tests
6.5.1 Next Generation Sequencing (Ngs)
6.5.2 Sanger Sequencing
7 Middle East And Africa Pharmacogenetic Testing Market, By Gene Type
7.1 Overview
7.2 Cyp2c19
7.3 Cyp2d6
7.4 Cyp2c9 And Vkorc1
7.5 Cyp1a2
7.6 Hla-b*1502
7.7 Hla-b*5701
7.8 Cyp2d
7.9 Oprm1
7.10 Oncotype Dx* And Mammaprint
7.11 Drd3
7.12 D4d4
7.13 Slc6a4
7.14 Htr2a/C
7.15 Tmpt
7.16 Others
8 Middle East And Africa Pharmacogenetic Testing Market, By Drug Type
8.1 Overview
8.2 Prescription Drugs
8.3 Nutraceuticals
8.4 Recreational Drugs
8.5 Herbal Supplements
8.6 Vitamins
8.7 Over-the-counter Medications
9 Middle East And Africa Pharmacogenetic Testing Market, By Sample
9.1 Overview
9.2 Blood
9.3 Saliva
10 Middle East And Africa Pharmacogenetic Testing Market, By Therapeutic Area
10.1 Overview
10.2 Cardiology
10.3 Gastroenterology
10.4 Anesthesiology
10.5 Genomics
10.6 Endocrinology
10.7 Immunology & Hypersensitivity
10.8 Dermatology
10.9 Gynecology
10.10 Oncology
10.11 Neurology
10.12 Others
11 Middle East And Africa Pharmacogenetic Testing Market, By Application
11.1 Overview
11.2 Clinical Practice
11.2.1 Side Effects
11.2.2 Drug Effectiveness
11.2.3 Dosage
11.3 Drug Development
11.3.1 Drug Effectiveness
11.3.2 Dosage
11.3.3 Side Effects
11.4 Drug Regulation
11.4.1 Side Effects
11.4.2 Drug Effectiveness
11.4.3 Dosage
12 Middle East And Africa Pharmacogenetic Testing Market, By End User
12.1 Overview
12.2 Healthcare Providers
12.3 Pharmaceutical & Biotechnology Companies
12.4 Research Centres And Academic Institutes
12.5 Others
13 Middle East And Africa Pharmacogenetic Testing Market, By Distribution Channel
13.1 Overview
13.2 Hospital Pharmacy
13.3 Retail Pharmacies
13.4 Mail-order Pharmacies
13.5 Direct-to-customer Services
14 Middle East And Africa Pharmacogenetic Testing Market, By Region
14.1 Middle East And Africa
15 Middle East And Africa Pharmacogenetic Testing Market: Company Landscape
15.1 Company Share Analysis: Middle East And Africa
16 Swot Analysis
17 Company Profile
17.1 Thermo Fisher Scientific Inc.
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Developments
17.2 Illumina, Inc.
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Development
17.3 Qiagen
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Recent Development
17.4 Sonic Healthcare
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Bgi
17.5.1 Company Snapshot
17.5.2 Company Share Analysis
17.5.3 Product Portfolio
17.5.4 Recent Development
17.6 23andme, Inc
17.6.1 Company Snapshot
17.6.2 Revenue Analysis
17.6.3 Product Portfolio
17.6.4 Recent Development
17.7 Dynamic Dna Laboratories
17.7.1 Company Snapshot
17.7.2 Product Portfolio
17.7.3 Recent Development
17.8 Eurofins Scientific (2022)
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Development
17.9 Genewix (A Subsidiary Of Azenta Life Science)
17.9.1 Company Snapshot
17.9.2 Product Portfolio
17.9.3 Recent Development
17.10 Luminex Corporation (A Subsidiary Of Diasorin)
17.10.1 Company Snapshot
17.10.2 Product Portfolio
17.10.3 Recent Development
17.11 Md Labs
17.11.1 Company Snapshot
17.11.2 Product Portfolio
17.11.3 Recent Development
17.12 Myriad Genetics, Inc.
17.12.1 Company Snapshot
17.12.2 Revenue Analysis
17.12.3 Product Portfolio
17.12.4 Recent Developments
17.13 Oneome
17.13.1 Company Snapshot
17.13.2 Product Portfolio
17.13.3 Recent Development
17.14 Pacbio
17.14.1 Company Snapshot
17.14.2 Revenue Analysis
17.14.3 Product Portfolio
17.14.4 Recent Development
17.15 Perkinelmer Inc.
17.15.1 Company Snapshot
17.15.2 Revenue Analysis
17.15.3 Product Portfolio
17.15.4 Recent Development
17.16 Pgxt
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 Middle East And Africa Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 2 Middle East And Africa Whole Genome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 3 Middle East And Africa Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 4 Middle East And Africa Whole Exome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 5 Middle East And Africa Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 6 Middle East And Africa Array-based Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 7 Middle East And Africa Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 8 Middle East And Africa Single Gene Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 9 Middle East And Africa Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 10 Middle East And Africa Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 11 Middle East And Africa Cyp2c19 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 12 Middle East And Africa Cyp2d6 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 13 Middle East And Africa Cyp2c9 And Vkorc1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 14 Middle East And Africa Cyp1a2 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 15 Middle East And Africa Hla-b*1502 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 16 Middle East And Africa Hla-b*5701 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 17 Middle East And Africa Cyp2d In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 18 Middle East And Africa Oprm1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 19 Middle East And Africa Oncotype Dx* And Mammaprint In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 20 Middle East And Africa Drd3 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 21 Middle East And Africa D4d4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 22 Middle East And Africa Slc6a4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 23 Middle East And Africa Htr2a/C In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 24 Middle East And Africa Tmpt In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 25 Middle East And Africa Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 26 Middle East And Africa Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 27 Middle East And Africa Prescription Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 28 Middle East And Africa Nutraceuticals In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 29 Middle East And Africa Recreational Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 30 Middle East And Africa Herbal Supplements In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 31 Middle East And Africa Vitamins In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 32 Middle East And Africa Over-the-counter Medications In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 33 Middle East And Africa Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 34 Middle East And Africa Blood In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 35 Middle East And Africa Saliva In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 36 Middle East And Africa Pharmacogenetic Testing Market, By Therpaeutic Area, 2021-2030 (Usd Million)
Table 37 Middle East And Africa Cardiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 38 Middle East And Africa Gastroenterology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 39 Middle East And Africa Anesthesiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 40 Middle East And Africa Genomics In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 41 Middle East And Africa Endocrinology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 42 Middle East And Africa Immunology & Hypersensitivity In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 43 Middle East And Africa Dermatology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 44 Middle East And Africa Gynecology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 45 Middle East And Africa Oncology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 46 Middle East And Africa Neurology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 47 Middle East And Africa Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 48 Middle East And Africa Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 49 Middle East And Africa Clinical Practice In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 50 Middle East And Africa Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 51 Middle East And Africa Drug Development In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 52 Middle East And Africa Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 53 Middle East And Africa Drug Regulation In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 54 Middle East And Africa Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 55 Middle East And Africa Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 56 Middle East And Africa Healthcare Providers In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 57 Middle East And Africa Pharmaceutical & Biotechnology Companies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 58 Middle East And Africa Research Centres And Academic Institutes In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 59 Middle East And Africa Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 60 Middle East And Africa Pharmacogenetic Testing Market, By Distribution Channel, 2020-2030 (Usd Million)
Table 61 Middle East And Africa Hospital Pharmacy In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 62 Middle East And Africa Retail Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 63 Middle East And Africa Mail-order Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 64 Middle East And Africa Direct-to-customer Services In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 65 Middle East And Africa Pharmacogenetic Testing Market, By Country, 2021-2030 (Usd Million)
Table 66 Middle East And Africa Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 67 Middle East And Africa Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 68 Middle East And Africa Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 69 Middle East And Africa Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 70 Middle East And Africa Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 71 Middle East And Africa Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 72 Middle East And Africa Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 73 Middle East And Africa Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 74 Middle East And Africa Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 75 Middle East And Africa Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 76 Middle East And Africa Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 77 Middle East And Africa Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 78 Middle East And Africa Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 79 Middle East And Africa Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 80 Middle East And Africa Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 81 South Africa Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 82 South Africa Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 83 South Africa Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 84 South Africa Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 85 South Africa Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 86 South Africa Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 87 South Africa Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 88 South Africa Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 89 South Africa Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 90 South Africa Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 91 South Africa Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 92 South Africa Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 93 South Africa Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 94 South Africa Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 95 South Africa Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 96 Saudi Arabia Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 97 Saudi Arabia Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 98 Saudi Arabia Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 99 Saudi Arabia Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 100 Saudi Arabia Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 101 Saudi Arabia Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 102 Saudi Arabia Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 103 Saudi Arabia Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 104 Saudi Arabia Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 105 Saudi Arabia Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 106 Saudi Arabia Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 107 Saudi Arabia Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 108 Saudi Arabia Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 109 Saudi Arabia Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 110 Saudi Arabia Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 111 U.A.E. Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 112 U.A.E. Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 113 U.A.E. Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 114 U.A.E. Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 115 U.A.E. Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 116 U.A.E. Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 117 U.A.E. Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 118 U.A.E. Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 119 U.A.E. Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 120 U.A.E. Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 121 U.A.E. Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 122 U.A.E. Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 123 U.A.E. Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 124 U.A.E. Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 125 U.A.E. Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 126 Israel Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 127 Israel Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 128 Israel Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 129 Israel Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 130 Israel Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 131 Israel Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 132 Israel Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 133 Israel Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 134 Israel Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 135 Israel Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 136 Israel Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 137 Israel Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 138 Israel Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 139 Israel Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 140 Israel Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 141 Egypt Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 142 Egypt Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 143 Egypt Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 144 Egypt Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 145 Egypt Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 146 Egypt Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 147 Egypt Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 148 Egypt Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 149 Egypt Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us